Sign In
Hemogenyx plc (AIM: HEMO)*: Secures £3m to accelerate Phase I trials and initiate early commercialisation of HG-CT-1Scancell Holdings plc (AIM: SCLP): Fast track designation for iSCIB1+ in advanced melanoma – Update from the SCOPE Phase II studyPoolbeg Pharma plc (AIM: POLB): 2025 full-year results
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
SP Angel Healthcare Conditions
Tue, 28th Apr 2026 10:14
Hemogenyx Pharmaceuticals (HEMO)
Follow the stocks
